抗酸剂
药代动力学
药理学
化学
溶解度
医学
生物化学
有机化学
作者
Manoli Vourvahis,Susana Banerjee,Robert R. LaBadie,David Gore,H. Mayer
摘要
ABSTRACT Lersivirine (UK-453,061) is a next-generation nonnucleoside reverse transcriptase inhibitor that displays potent antiviral activity. Lersivirine solubility is pH dependent; therefore, the effect of coadministration of antacid on the pharmacokinetics of lersivirine in healthy subjects was investigated. The ratio of adjusted geometric means (750 mg lersivirine plus 20 ml Maalox Max/750 mg lersivirine alone) for the area under the curve from time zero extrapolated to infinite time (AUC inf ) was 101.86%, showing that coadministration of an antacid had no effect on lersivirine exposure. Coadministration appeared to be safe and relatively well tolerated.
科研通智能强力驱动
Strongly Powered by AbleSci AI